ARWR

ARWR

USD

Arrowhead Pharmaceuticals Inc. Common Stock

$16.740-0.430 (-2.504%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$17.170

High

$17.490

Low

$16.685

Volume

1.22M

Company Fundamentals

Market Cap

2.3B

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.84M

Exchange

NMS

Currency

USD

52-Week Range

Low $9.57Current $16.740High $30.41

Related News

BusinessWire

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity

ARO-ALK7 is the first investigational RNAi therapeutic to enter clinical studies that targets a gene expressed in adipose tissue Study initiation highlights Arrowhead's leadership in the delivery of siRNA to

View more
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-ALK7 for the Treatment of Obesity
BusinessWire

Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it is scheduled to participate in the following upcoming investor events: Jefferies Global Healthcare Conference – June 4-5, 2025 Type: Fireside

View more
Arrowhead Pharmaceuticals to Participate in June 2025 Investor Conferences
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Arrowhead Pharma with a Buy and maintains $80 price target.

View more
HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $80 Price Target